INTRODUCTION AND OBJECTIVES:
Upper urinary tract urothelial carcinoma (UTUC) is a relatively rare disease which accounts for 5-10% of all urothelial malignancies, and its molecular biology is poorly understood. We comprehensively investigated the genetic alterations of this disease.
METHODS: Surgical specimens of UTUC and matched normal samples were obtained from 102 patients with various stages who underwent nephroureterectomy, and were subjected to whole exome/ RNA sequencing and methylation array.
RESULTS: UTUC displayed a large number of mutations with 5.3 mutations per megabase (Mb). 7 cases showed hypermutation (>20/Mb), 6 of which harbored biallelic mismatch repair (MMR) gene alterations, supporting UTUC is a Lynch syndrome-associated cancer. Genetic alterations were most frequently observed in TERT promoter (51% of cases), followed by KMT2D (48%), FGFR3 (46%, including fusion genes), CDKN2A (homozygous deletion) (42%), TP53 (31%), and RAS family genes (HRAS/KRAS/NRAS, 21%). More than 95% cases harbored either TP53, MDM2, FGFR3, or RAS alterations in almost mutually exclusive manner. Hierarchical clustering of frequently altered genes in 95 non-hypermutated cases identified 3 distinct subgroups. Group 1 is characterized by frequent TP53/MDM2 alterations with complex copy number alterations (CNAs), high stage/grade, and poor prognosis. Group2 is enriched in FGFR3 and CDKN2A alterations, showing simple CNAs, low stage/grade, and favorable prognosis. All cases in Group3 harbored RAS-family gene alterations. Gene expression analysis with unsupervised clustering identified 3 clusters. Cluster 1 was enriched for TP53 defective cases, showing high expression of late cell-cycle genes and basal markers. On the other hand, cluster 2 and 3 showed high expression of early cell cycle genes and luminal markers. Cases in cluster 2 were mainly FGFR3-mutanted cases (75%) while almost all of the RAS-mutated cases were classified in cluster 3 (92%). Notably, cluster 1, which showed poor prognosis, had significantly high expression of the immune blockade target CD274 and PDCD1LG2.Hierarchical analysis of methylation data revealed that approximately 60% of examined samples showed extensive hypermethylation (CIMPþ). However, there was no significant correlation with the mutation subtypes.
CONCLUSIONS: UTUC showed distinct genetic landscape in terms of mutations, which was also associated with prognosis, clinical features, and expression pattern. Our findings of molecular characteristics of UTUC will contribute to the development of new potential diagnostics and therapeutics. METHODS: Expression of IFIT5 in BCa tissues were investigated by immunohistochemical staining and database (TCGA and GEO) retrieving. Stable IFIT5 over-expression or knock-down BCa cell sublines were generated to investigate the role of IFIT5 on epithelialmesenchymal transition (EMT), cell migration and invasion in vitro. MicroRNA PCR array and qRT-PCR were used to verify the specific microRNA regulated by IFIT5. Direct target of the specific microRNA was verified by dual luciferase reporter assay, and their relationship with IFIT5 was analyzed by western blot. Subcutaneous xenograft model was used to investigate the effects of IFIT5 on tumorigenesis and verify the in vitro data.
RESULTS: IFIT5 expression was higher in high-grade, carcinoma in situ (CIS)-positive or muscle-invasive BCa tissues, which predicted a poor survival of patients. Over-expression of IFIT5 in 5637 and 253J cells induced EMT, promoted cell migration and invasion, and decreased the expression of mature miR-99a, meanwhile knock-down of IFIT5 in UM-UC-3 and TCCSUP cells inhibited EMT, suppressed cell migration and invasion, and increased the expression of mature miR99a. However, either over-expression or knock-down of IFIT5 had no effect on the expression of pre-miR-99a and pri-miR-99a. Furthermore, ICAM1 was shown as a direct target of miR-99a, and over-expression of miR-99a in IFIT5 over-expressing 5637 and 253J cells could reverse EMT, suppress cell migration and invasion, and decrease ICAM1 expression induced by IFIT5. In addition, overexpression of IFIT5 could enhance BCa tumorigenecity, and the expression of mature miR-99a was negatively regulated.
CONCLUSIONS: Interferon-induced gene IFIT5 may acts as an oncogene in BCa relapse and progression after BCG treatment, which induces EMT, promote cell migration and invasion, and increase the expression of ICAM1 via down-regulation of mature miR-99a.
Source of Funding:
Grants from the National Natural Science Foundation of China (NSFC 81572516 to KW) and First Affiliated Hospital of Xi'an Jiaotong University (15YB08 to JH).
MP58-11 THE DUAL-STRANDED MICRORNA-199 FAMILY MEMBERS HAVE TUMOR-SUPPRESSIVE FUNCTION VIA DIRECTLY TARGETING INTEGRIN a3 (ITGA3) AS A POTENTIAL THERAPEUTIC TARGET IN BLADDER CANCER
Takashi Sakaguchi*, Hirofumi Yoshino, Satoshi Sugita, Masaya Yonemori, Kazutaka Miyamoto, Youichi Osako, Shuichi Tatarano, Takashi Yamane, Masayuki Nakagawa, Hideki Enokida, Kagoshima, Japan INTRODUCTION AND OBJECTIVES: The molecular mechanisms of muscle invasion in bladder cancer (BC) are still unknown. Based on the microRNA (miRNA) signature of BC by deep sequencing, we recently found that several double-stranded mature miRNAs derived from the same pre-miRNAs acted as tumor suppressors by regulating common target genes. In this study, we focused on miR-199 family members (miR-199a-3p/-5p and miR-199b-3p/-5p) that were downregulated in the signature. The aim of this study was to investigate the functional role of miR-199 family members and to identify molecular targets that contribute to tumor invasion in BC.
METHODS: Expression levels of these miRNAs in 32 BC clinical samples and 12 normal bladder epithelia (NBE) and cell lines (T24 and BOY) were evaluated by qRT-PCR. Cell proliferation, migration, and invasion assays were performed in these miRNAs transfected BC cells. In silico analysis by using TargetScan and GEO database were applied to identify candidate target genes of these miRNAs. Luciferase reporter assays were carried out to determine whether these miRNAs directly bind to the target gene. We performed loss-of-function studies by using si-RNA transfectants to evaluate the functional role of target gene. We confirmed the target gene expression and the correlations between miR-199 family and the target gene expression by The Cancer Genome Atlas (TCGA) database (408 BCs and 19 NBE).
RESULTS: The expression levels of these miRNAs were significantly reduced in clinical BCs (P < 0.005). Restoration of these miRNAs significantly inhibited cell migration and invasion in BC cells (P < 0.0001). Luciferase reporter assays identified integrin a3 (ITGA3) as a target gene directly regulated by these miRNAs. TCGA database showed that ITGA3 expression was significantly upregulated in BC compared with NBE (P ¼ 0.0063) and there were significant negative correlations between ITGA3 and miR-199 family expression (P < 0.05). Immunohistochemistry demonstrated ITGA3 expression was significantly upregulated in BCs compared with NBE (P ¼ 0.0038) and highly expressed in patients with advanced tumor stage (T2 or more) (P ¼ 0.048). Loss-of-function study showed that cell migration and invasion were significantly inhibited in si-ITGA3 transfectans (P < 0.0001).
CONCLUSIONS: Recent studies showed that ITGA3 functions as extracellular matrix (ECM) receptor and contributes to cancer cell migration and invasion. Our data suggested that ITGA3 was directly regulated by miR-199 family and could be a novel therapeutic target in BC.
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MP58-12 A FOUR MIRNAS SIGNATURE AS A POTENTIAL BIOMARKER FOR PREDICTING SURVIVAL USING BIOINFORMATICS ANALYSIS IN BLADDER CANCER
He Xiao, Ping Chen, Deqiang Xu, Wuhan, China, People's Republic of; Michael E DiSanto, Camden, NJ; Xinhua Zhang, Xinhua Zhang*, Wuhan, China, People's Republic of INTRODUCTION AND OBJECTIVES: Human bladder cancer (BCa) is a common disease, with the etiology and mechanism unknown. Accumulated evidence shows that micro RNAs (miRNAs) play vital roles and can be used as biomarkers for many types of cancers. The aim of this study is to use bioinformatics analysis to identify the key miRNAs and potential target genes, as well as studying the underlying mechanisms for BCa.
METHODS: The raw sequencing data and clinical information were downloaded from TCGA database. The miRNA profiles were normalized by log2 transformed. Subsequently, a prognostic miRNA signature was constructed, and the miRNA signature could calculate a risk score for each bladder cancer patient. The target genes of prognostic miRNAs were predicted using TargetScan, miRDB, PicTar, and miRanda online analysis tools. To further enhance the bioinformatics analysis reliability, the overlapping target genes were identified using Venn diagram and the Database for Annotation, Visualization and Integrated Discovery bioinformatics tool.
RESULTS: In the present study, a total of 407 samples were enrolled and 348 differentially expressed miRNAs were identified between bladder cancer tissues and normal tissues, including 264 upregulated miRNAs and 84 down-regulated miRNAs. Meanwhile, the Kaplan-Meier survival method revealed that the prognostic function of four miRNAs (miRNA-217, miRNA-378c, miR-33b and miRNA-615). miR-217, miR-33b and miR-615 were positively associated to overall survival (OS), while miR-378c was reversely correlated with OS. Interestingly, univariate and multivariate Cox regression analyses showed that the four-miRNA (miRNA-217, miRNA-378c, miR-33b and miRNA-615) signature was an independent prognostic factor in bladder cancer. The functional enrichment analysis showed that the target genes of four miRNAs might be involved in various pathways related to cancer signaling pathways, including Notch signaling pathway, PI3K-Akt signaling pathway, p53 signaling pathway, cGMP-PKG signaling pathway, FoxO and signaling pathway.
CONCLUSIONS: This study identified, for the first time, a fourmiRNA signature as a potential prognostic predictor for bladder cancer patients. Further studies are needed to validate our findings in large sample size, and function investigations are also required to explore the molecular mechanisms of these miRNAs in bladder cancer progression.
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MP58-13 THE ROLE OF G8 SCREENING TOOL IN ELDERLY POPULATION UNDERGOING RADICAL CYSTECTOMY: PRELIMINARY EVALUATION
Riccardo Boschian, Nicola Pavan*, Enrica Verzotti, Tommaso Silvestri, Fabio Traunero, Giovanni Liguori, Carlo Trombetta, Trieste, Italy INTRODUCTION AND OBJECTIVES: The G8 screening tool represents a valid instrument for the identification of functional decline in oncological geriatric patients (pts). Recently it has demonstrated good predictive value in surgery to identify fragile pts candidates for oncological abdominal surgery. Our study has the objective to define if G8 score is a good tool to identify the risk of post operative complications in elderly pts (¼ 70 years) undergoing radical cystectomy (RC).
METHODS: From January 2012 to August 2017 we recruited 56 pts 70 yrs or older at the surgical time, undergone RC. Median age was 76 yrs (SD 4,37). The G8 screening questionnaire was perfomed to all patients preoperatively, and fragile pts were identified with a score ¼ 14. We registered intra operative complications, post operative complications and their gravity using Clavien Dindo scale, estimated glomerular filtration rate (eGFR) and its variation postoperatively, length of hospital stay after surgery and readmission rate within 30 days. We compared the clinicalpathological data between the frail (G8 score <¼14) and not frail (G8 score >14) group. Statistical analysis was made by computing software SPSS.
RESULTS: Median preoperative G8 score was 13,65 (SD 2,3). Pts were divided in fragile (N¼35, 62,5%) and fit (N¼21, 37,5%). Intra operative complications were registered in 1 pts (2,8 %) with G8 score ¼14 and 0 pt (0%) with G8>14 (p¼ 0,625). Post operative complications occurred in 24 pts (68,5 %) with G8 score ¼14 and 8 pts (38,09 %) with G8>14 (p¼0,025), 12 and none of them had a Clavien Score ¼ 3 respectevely (p¼ 0,015). Postoperative eGFR was 61,45 (SD 29,2) in G8¼14 group and 57,66 (SD 25, 84) in G8>14 group (p¼0, 62) and median variation between pre and postoperative eGFR was 7,8 (SD 27,43) and 8,0 (SD 26,01) for each group (p¼ 0,97). Median hospital stay was 25,45 days (SD 11,01) for fragile pts and 24,23 days (SD 11,32) for fit pts (p¼0,69). 5 pts (14,28 %) with G8score¼14 were readmitted within 30 days of discharge, and for 6 pts (28,57 %) with G8score>14 was necessary a new hospitalization (p¼ 0,298). No significative difference was registered for overall mortality (p¼ 0,23) and cancer related mortality (p¼ 0,53) between the two groups.
